GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Senomyx Inc (NAS:SNMX) » Definitions » Accounts Receivable

Senomyx (Senomyx) Accounts Receivable : $2.19 Mil (As of Jun. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Senomyx Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Senomyx's accounts receivables for the quarter that ended in Jun. 2018 was $2.19 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Senomyx's Days Sales Outstanding for the quarter that ended in Jun. 2018 was 60.72.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Senomyx's Net-Net Working Capital per share for the quarter that ended in Jun. 2018 was $0.21.


Senomyx Accounts Receivable Historical Data

The historical data trend for Senomyx's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senomyx Accounts Receivable Chart

Senomyx Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.13 2.28 3.19 5.35 7.13

Senomyx Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.81 5.18 7.13 1.83 2.19

Senomyx Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Senomyx Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Senomyx's Days Sales Outstanding for the quarter that ended in Jun. 2018 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=2.186/3.285*91
=60.72

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Senomyx's accounts receivable are only considered to be worth 75% of book value:

Senomyx's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2018 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(14.659+0.75 * 2.186+0.5 * 1.891-7.333
-0-0)/48.3383
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Senomyx Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Senomyx's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Senomyx (Senomyx) Business Description

Traded in Other Exchanges
N/A
Address
Senomyx Inc manufactures and sells a variety of favors for the packaged food, beverage, and ingredient supply industries. The firm's product portfolio has three primary categories: sweetmyx, savorymyx, and bittermyx. Sweetmyx ingredients are used to increase a product's sweet taste while reducing sugar usage. Savorymyx ingredients are used to increase a product's savory flavors as well as reduce MSG, nucleotides, and sodium in food and beverage products. Bittermyx ingredients are used to reduce a product's bitter taste.
Executives
Christopher J Twomey director 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA 92121
John Poyhonen director, officer: President & CEO 11088 N TORREY PINES RD, C/O SENOMYX INC, LA JOLLA CA 92037
Stephen A Block director INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 WEST 57TH ST, NEW YORK NY 10019
Mary Ann Gray director 201 W 70TH ST, SUITE 23K, NEW YORK NY 10023
Richard R Mashaal 10 percent owner C/O RIMA SENVEST MANAGEMENT, L.L.C., 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Senvest Management, Llc 10 percent owner 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Michael E Herman director CERNER CORP 2800 ROCKCREEK PARKWAY KANSAS CITY MO 64117-2551
David B Berger officer: Sr. V.P. Gen. Counsel & Sec. 11045 ROSELLE STREET, SAN DIEGO CA 92121
Dennis F Obrien director SENOMYX INC, 11099 NORTH TORREY PINES ROAD, LA JOLLA CA 92037
Harry J Leonhardt officer: SVP, Gen.Counsel & Corp. Sec. C/O HALOZYME THERAPEUTICS, INC., 11388 SORRENTO VALLEY BLVD., SAN DIEGO CA 92121
Mark Leschly director RHO CAPITAL PARTNERS, INC., 152 W 57TH ST 23RD FL, NEW YORK NY 10019
David Schnell director 525 UNIVERSITY AVE, SUITE 1350, PALO ALTO CA 94301
Timothy J Wollaeger director
Beeley Nigel R A officer: VP Discovery ARENA PHARMACEUTICALS INC 6166 NANCY RIDER DRIVER SAN DIEGO CA 92121
Rho Management Trust I 10 percent owner C/O RHO CAPITAL PARTNERS, INC., 152 W. 57TH STREET, 23RD FLOOR, NEW YORK NY 10019

Senomyx (Senomyx) Headlines

From GuruFocus

Senomyx Reports Second Quarter 2018 Financial Results

By PRNewswire PRNewswire 08-03-2018

Senomyx Appoints Tom Erdmann to Board of Directors

By PRNewswire PRNewswire 03-22-2018

Senomyx Inc. Reports Operating Results (10-K)

By gurufocus 10qk 02-04-2010

Senomyx Reports First Quarter 2018 Financial Results

By PRNewswire PRNewswire 04-27-2018

Senomyx Inc. Reports Operating Results (10-K)

By gurufocus 10qk 03-03-2011

FIRMENICH COMMENCES TENDER OFFER TO ACQUIRE SENOMYX

By PRNewswire PRNewswire 10-04-2018

WeissLaw LLP Investigates Senomyx, Inc. Acquisition

By PRNewswire PRNewswire 10-09-2018

FIRMENICH TO ACQUIRE SENOMYX, PIONEER IN TASTE INNOVATION

By PRNewswire PRNewswire 09-17-2018